Laddar...
Advances in reducing cardiovascular risk in the management of patients with type 2 diabetes mellitus
Treatment intended to lower cardiovascular (CV) risk in patients with diabetes has always been a primary goal of diabetes treatment. Due to the subdued effects of reducing hemoglobin A1c (HbA1c) on macrovascular complications, controlling other CV risk factors such as hypertension and hyperlipidemia...
Sparad:
| I publikationen: | Chronic Dis Transl Med |
|---|---|
| Huvudupphovsman: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Chinese Medical Association
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6449766/ https://ncbi.nlm.nih.gov/pubmed/30993261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cdtm.2019.01.001 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|